Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression
Clinical trial NCT05323019 · TERMINATED
Trial details
- NCT number
- NCT05323019
- Sponsor
- Zylorion Health
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-13
- Primary completion
- 2023-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.